UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549





CURRENT  REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  March 14, 2017

________________________

CRYOLIFE, INC.

(Exact name of registrant as specified in its charter)
_________________________





1655 Roberts Boulevard, N.W.,  Kennesaw,  Georgia  30144
(Address of principal executive office) (zip code)

Registrant's telephone number, including area code: (770) 419-3355

_____________________________________________________________

(Former name or former address, if changed since last report)

_________________________



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):



☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)



☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))



☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



---

 



Mr. James S. Benson, a director of CryoLife, Inc. (“the Company”) since 2005, notified the Company on March 14, 2017, of his decision not to stand for re-election as a director at the Company’s 2017 Annual Meeting of Shareholders. Mr. Benson’s decision not to stand for re-election was not due to any disagreement with management on any matter relating to the Company’s operations, policies, or practices.  









 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



CRYOLIFE, INC.







Date:  March 16, 2017





















---